Duce Management, LLC

Overview

Led by Marc Duey, Managing Partner, Duce Management invests in emerging companies whose intellectual property and platform technologies may appeal to specialty pharmaceutical manufacturers.¹

History

The firm has operated under Marc Duey’s leadership since 2012. Before Duce Management, Duey founded ProMetrics, a specialty-pharmaceutical data and services company that supported more than 150 clients and thousands of projects.²¹

Leadership

Marc Duey serves as Managing Partner. He has more than three decades of pharmaceutical and biotechnology experience. He also serves on technology-company boards, teaches at West Chester University, serves on the Board of Trustees of International House Philadelphia, and participates in the Wistar Institute Leadership Council.¹

Services

Duce Management makes early-stage commitments and supports portfolio companies with commercial-business and product-launch experience. Its stated approach is to back science-driven companies whose platforms may advance drug discovery, patient engagement, diagnostics, or therapeutic development.¹

Client Focus

The firm focuses on emerging biotechnology and digital health companies, with particular interest in potential therapies for cancer, immunological disorders, and cardiovascular disease.¹

Duce Management reports that its portfolio includes Atrin Pharmaceuticals, Cassian Solutions, Felicitex Therapeutics, West Chester Biomedical AI Solutions, TarMeta Biosciences, and Adipoligo Health Sciences. The firm also reports that seven client biotech firms were acquired by seven large oncology companies, with total transaction value exceeding $150 billion.¹

Approach

Duce Management seeks science-driven businesses with proprietary intellectual property or platform technologies that can support advances in drug discovery, diagnostics, patient engagement, or therapeutic development.¹

FAQs

Related resources

• LocationMultifamily offices in Pennsylvania

  The Pennsylvania multifamily offices page gives a regional starting point for comparing office structures, investment scopes, and client arrangements. For a reader considering Duce Management, LLC, it can help frame questions about whether an early-stage biotechnology and digital health focus fits broader family office needs.

• GuideMultifamily office services

  The multifamily office services page outlines common support areas a family or business owner may expect, from investment oversight to administrative coordination. This helps readers assess which services they may need alongside Duce Management, LLC's focus on early-stage biotechnology and digital health opportunities.

• GuideHow to choose a multifamily office

  The guide on how to choose a multifamily office provides questions for reviewing investment focus, communication practices, client fit, and decision-making structure. A reader can use those points to examine whether Duce Management, LLC's early-stage biotechnology and digital health strategy matches the family's objectives and preferences.

• GuideOutsourced CIO vs multifamily office

  The comparison of an outsourced CIO and a multifamily office explains how investment leadership, reporting, and broader family support may differ. It gives a prospective client a framework for deciding whether Duce Management, LLC's investment fund focus suits the role they want from an external partner.

• Similar firmsApex Financial Advisors, Inc.
  The Aranda Group Advisors, LLC
  Aspire Universal

  Profiles of Apex Financial Advisors, Inc., The Aranda Group Advisors, LLC, and Aspire Universal offer additional examples of firms listed on MultifamilyOffices.com. Reviewing them alongside Duce Management, LLC can help a reader compare stated services, investment emphasis, and the types of families or owners each profile addresses.

Sources

1. Duce Management, LLC
2. Aprea Therapeutics investor document

Claim or correct this profile

This profile is a factual summary written in our own words from public sources. It is for information only. It is not an endorsement, rating, ranking or recommendation, and it is not investment advice. MultiFamilyOffices.com is not affiliated with the SEC or with this firm unless stated. Form ADV figures are self-reported by the firm.